2021
DOI: 10.1002/pds.5303
|View full text |Cite
|
Sign up to set email alerts
|

Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes

Abstract: Background Although prior literature suggests that metoprolol may worsen glucose control compared to carvedilol, whether this has clinical relevance among older adults with diabetes and heart failure (HF) remains an open question. Methods This was a US retrospective cohort study utilizing data sourced from a 50% national sample of Medicare fee‐for‐service claims of patients with part D prescription drug coverage (2007–2017). Among patients with diabetes and HF, we identified initiators of metoprolol or carvedi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…This approach provides a simple, yet effective, strategy to deliver CAR for the management of symptomatic chronic heart failure. It has been reported that CAR is frequently prescribed to multimorbid individuals with heart failure and these patients are most prevalent within the geriatric patient group (7,8). Since approximately 15-20% of geriatric patients typically suffer dysphagia, the use of MAPs to deliver CAR transdermally is a great advantage, circumventing the need for an oral-based delivery system and the drawbacks that accompany it (9).…”
Section: Introductionmentioning
confidence: 99%
“…This approach provides a simple, yet effective, strategy to deliver CAR for the management of symptomatic chronic heart failure. It has been reported that CAR is frequently prescribed to multimorbid individuals with heart failure and these patients are most prevalent within the geriatric patient group (7,8). Since approximately 15-20% of geriatric patients typically suffer dysphagia, the use of MAPs to deliver CAR transdermally is a great advantage, circumventing the need for an oral-based delivery system and the drawbacks that accompany it (9).…”
Section: Introductionmentioning
confidence: 99%